Nema internetske veze — prikazuje se spremljena verzija stranice.

Grifols S.A

USUSD
← Na Filtar Dionica

Grifols S.A (LSE:0RDU) — Drug Manufacturers - General. Broj burzi na kojima se trguje dionicama tvrtke: 4. Na ovoj stranici — cijena i grafikon, dividende, najveći dioničari i povijest broja dionica.

⚠ Nemojte brkati: postoji još jedna tvrtka s istim ili vrlo sličnim imenom. Ovo je zaseban zapis — provjerite ticker, burzu i registracijski broj.
  • Grifols SA — GRF-P · MC ES Registarski broj nepoznat

O Tvrtki

Web-Stranica
grifols.com
Odnosi s Investitorima
grifols.com/en/investors
Sektor
Healthcare · Drug Manufacturers - General
Sjedište
NEW YORK, Spain
Glavni Direktor
Jose Ignacio Abia Buenache
Zaposlenici
25 258
Osnovana
1909
Na Burzi od
23.11.2007 (LSE:0RDU)
Dionice u Optjecaju
422.36 mil.
Slobodno Prenosive Dionice
418.2 mil.
Tržišna Kapitalizacija
7.57 mlrd. USD
Insajderi
31.19%
Institucionalni Ulagači
37.75%
Djelatnost (SIC)
Pharmaceutical Preparations
Pravni Oblik
5RDO
ISIN
ES0171996012
LEI
959800HSSNXWRKBK4N60
Omjer Isplate
≈7.7%
FCF
641 mil. EUR
Isplata / FCF
5%
Dug
8.52 mlrd. EUR
11 g. FCF
Dividendni Staž
1 g.
Zarada, FCF i isplaćene dividende — za 12 mjeseci do 30.06.2026 (najnovije izvješće tvrtke).
Opis

Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services. It also offers biological products, including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products to pharma and biotech companies for biopharma use; and whole blood, blood components, processed plasma, and clinical samples to life-science research and in-vitro diagnostic companies for diagnostic use. In addition, the company provides healthcare solutions for hospitals, such as intravenous solutions to maintain or restore fluids and electrolyte balance in patients; high-tech solutions to automate hospital processes; clinical nutrition to deliver nutrition and medication; and medical devices comprising instrumentation and disposable materials for various hospital services, which include interventional neuroradiology, hemodynamics, urology, anesthesiology and cardiovascular surgery, as well as manufacturing services to third parties and research activities. Further, it is involved in engineering services; packaging, labelling, storage, distribution, manufacturing, and development of pharmaceutical products; import, export, and commercialization activities; travel agency services; reinsurance of insurance policies; support services; law business; and consultation, administration, and financing services. The company was founded in 1909 and is headquartered in Barcelona, Spain.

oglas

Burze i Oznake

BurzaOznakaValutaCijenaVrsta
US USA StocksGIFLF OTCUSD10.547 -5.24%obične dionice
LSE London Stock Exchange0RDU IOBEUR16.125 +0.00%obične dionice
MC Bolsa de MadridGRF glavnaEUR9.8 +1.43%obične dionice
VI Vienna Stock ExchangeGRF dodatnaEUR9.962 +0.99%obične dionice

Cijena za 3 Mjeseca

dan rasta dan pada ex-dividendni datum datum isplatePrijeđite mišem / dodirnite dan — cijene otvaranja, zatvaranja, najviša i najniža

Dividende

Grifols S.A (GIFLF) isplaćuje dividende jednom godišnje.

Ex-DatumIsplataIznos%VrstaOznaka
2026-07-012026-07-020.0824 EUR0.9 %posebnaUS:GIFLF
2025-08-122025-08-130.1500 EUR1.2 %posebnaUS:GIFLF

Najveći Imatelji

ImateljUdioDioniceDatum Izvješća
VANGUARD STAR FUNDS-Vang…1%4.28 mil.2026-04-30
VANGUARD TAX-MANAGED FUN…0.66%2.8 mil.2026-06-30
iShares Trust-iShares Co…0.49%2.08 mil.2026-07-31
DFA INVESTMENT DIMENSION…0.34%1.46 mil.2026-04-30
Dimensional ETF Trust-Di…0.25%1.07 mil.2026-04-30
iShares Trust-iShares MS…0.22%935 1282026-07-31
DFA INVESTMENT TRUST CO-…0.17%741 7722026-04-30
VANGUARD Intl Eqy. INDEX…0.16%696 5102026-04-30
SCHWAB STRATEGIC TRUST-S…0.16%676 4822026-05-31
VANGUARD Intl Eqy. INDEX…0.15%634 2982026-04-30
Pacer Advisors, Inc.0%1 3232026-06-30